These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18595553)

  • 1. Treatment of movement disorder emergencies.
    Frucht SJ
    Neurotherapeutics; 2014 Jan; 11(1):208-12. PubMed ID: 24356784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects.
    Cascorbi I
    Clin Pharmacol Ther; 2023 Nov; 114(5):943-946. PubMed ID: 37828691
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentially Life-Threatening Adverse Effect of Antiseizure Medications.
    Aschenbrenner DS
    Am J Nurs; 2024 Apr; 124(4):23. PubMed ID: 38511705
    [No Abstract]   [Full Text] [Related]  

  • 4. Knowledge, Preference, and Adverse Effects of Xylazine Among Adults in Substance Use Treatment.
    Hochheimer M; Strickland JC; Rabinowitz JA; Ellis JD; Dunn KE; Huhn AS
    JAMA Netw Open; 2024 Feb; 7(2):e240572. PubMed ID: 38416493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Books:
    Kemple T
    Br J Gen Pract; 2022 Nov; 72(724):539. PubMed ID: 36302682
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticipating, investigating and managing the adverse effects of drugs.
    Pirmohamed M
    Clin Med (Lond); 2005; 5(1):23-6. PubMed ID: 15745193
    [No Abstract]   [Full Text] [Related]  

  • 7. Iatrogenic Disorders.
    Krishnan NR; Kasthuri AS
    Med J Armed Forces India; 2005 Jan; 61(1):2-6. PubMed ID: 27407693
    [No Abstract]   [Full Text] [Related]  

  • 8. Movement disorders in emergency settings: a prospective study.
    Dallocchio C; Matinella A; Arbasino C; Arno' N; Glorioso M; Sciarretta M; Braga M; Tinazzi M
    Neurol Sci; 2019 Jan; 40(1):133-138. PubMed ID: 30324251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Movement Disorders Emergencies.
    Rajan S; Kaas B; Moukheiber E
    Semin Neurol; 2019 Feb; 39(1):125-136. PubMed ID: 30743298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Movement disorder emergencies in the elderly: recognizing and treating an often-iatrogenic problem.
    Tousi B
    Cleve Clin J Med; 2008 Jun; 75(6):449-57. PubMed ID: 18595553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Movement disorders induced by deep brain stimulation.
    Baizabal-Carvallo JF; Jankovic J
    Parkinsonism Relat Disord; 2016 Apr; 25():1-9. PubMed ID: 26806438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of psychiatric symptoms after deep brain stimulation for movement disorders.
    Quinn DK; Deligtisch A; Rees C; Brodsky A; Evans D; Khafaja M; Abbott CC
    Neuromodulation; 2014 Oct; 17(7):629-36; discussion 636. PubMed ID: 24512146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History, applications, and mechanisms of deep brain stimulation.
    Miocinovic S; Somayajula S; Chitnis S; Vitek JL
    JAMA Neurol; 2013 Feb; 70(2):163-71. PubMed ID: 23407652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Movement disorder emergencies.
    Poston KL; Frucht SJ
    J Neurol; 2008 Aug; 255 Suppl 4():2-13. PubMed ID: 18821080
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.